GRFFF yields 7.93% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GRFFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRFFF + PFE for your $10,000?
Fibra Danhos is a Mexican trust established primarily to develop, own, lease, operate and acquire iconic and premier quality commercial real estate assets in Mexico. Our goal is to provide attractive risk-adjusted returns for Holders of our CBFIs in the long term, through stable cash distributions and the appreciation of our properties. We will seek to maintain and grow a portfolio of high-quality properties, through our unmatched development capabilities, and the selective acquisition of iconic and premier-quality properties. We consider a property to be iconic if it has the unique ability to transform the surroundings in which it is located and we consider a property to be of premier quality if it is in prominent locations, it has been developed with the highest standards of construction and design, comprised of high-quality tenants, reports high occupancy rates and, in the case of commercial properties, reports a high volume of visitors.
Full GRFFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.